Blackford Analysis

Blackford Analysis is a healthcare technology company founded in 2010 and headquartered in Edinburgh, Scotland, with operations in the United States. The company is recognized as a pioneer in AI orchestration for medical imaging. In 2016, Blackford launched the industry's first AI orchestration platform, which enables radiology departments to evaluate, deploy, and manage AI imaging applications at scale. The Blackford Platform offers a portfolio of more than 130 AI applications from over 45 partner vendors, providing health systems with a single, vendor-neutral way to bring best-of-breed AI into the imaging workflow without disrupting existing operations. The platform is deployed by leading original equipment manufacturers (OEMs) and hospitals across various world markets. In October 2026, Sopris Capital, a multi-strategy investment firm with a deep healthcare technology portfolio, acquired Blackford Analysis from Bayer. Following the acquisition, Sopris is combining Blackford under its portfolio company Azra AI, a healthcare AI platform focused on identifying, connecting, and managing patients with cancer and other complex illnesses. Blackford will continue to operate as a separate legal entity with operations in Scotland and the United States, serving its existing OEM partners and health system customers without disruption. The combination with Azra AI is expected to be completed in the coming days or weeks, after which a further announcement will be made. Blackford Analysis remains active and is positioned as a trusted infrastructure partner for radiology departments seeking to implement AI at scale.

Blackford Analysis was founded in 2010 and is headquartered in Edinburgh, Scotland, with operations in the United States. The company emerged as a pioneer in AI orchestration for medical imaging. In 2016, Blackford launched the industry's first AI orchestration platform, which allowed radiology departments to evaluate, deploy, and manage AI imaging applications at scale. The Blackford Platform grew to include a portfolio of more than 130 AI applications from over 45 partner vendors, providing health systems with a single, vendor-neutral way to integrate best-of-breed AI into imaging workflows without disrupting existing operations. The platform has been deployed by leading original equipment manufacturers (OEMs) and hospitals across various world markets. At some point prior to October 2026, Blackford Analysis was acquired by Bayer, the multinational pharmaceutical and life sciences company. On October 9, 2026, Sopris Capital, a multi-strategy investment firm with a deep and growing portfolio of healthcare technology companies, announced it had completed the acquisition of Blackford Analysis from Bayer. Following the acquisition, Sopris began combining Blackford under one of its top-performing portfolio companies, Azra AI, a healthcare AI platform built to identify, connect, and manage patients with cancer and other complex illnesses across the care journey. Blackford continues to operate as a separate legal entity with operations in Scotland and the United States, serving its existing OEM partners and health system customers without disruption. The combination with Azra AI is expected to be completed in the coming days or weeks, after which a further announcement will be made.

• Blackford Analysis founded.

• Launched the industry's first AI orchestration platform for medical imaging.

• Acquired by Sopris Capital from Bayer; to be combined with Azra AI.

Vendor-neutral AI orchestration platform for medical imaging, enabling health systems to deploy and manage AI applications at scale without disrupting existing workflows.

• Blackford Platform

  AI orchestration platform for medical imaging with a portfolio of more than 130 AI applications from over 45 partner vendors, providing a single, vendor-neutral way to deploy AI in radiology workflows.

• 2026-10-09

  Sopris Capital completes acquisition of Blackford Analysis from Bayer[1]Sopris Capital Acquires Blackford Analysis, Strengthening AI Orchestration Capabilities Across Its HealthTech Portfolioprnewswire.com

  Reported: 2026-10-09

  Sopris Capital announced on Oct 9, 2026 that it has completed the acquisition of Blackford Analysis, an AI orchestration platform for medical imaging, from Bayer. Sopris is in the process of combining Blackford under its portfolio company Azra AI, a step expected to be completed in the coming days/weeks, and Blackford will continue to operate as a separate legal entity with operations in Scotland and the United States.

1. 1Sopris Capital Acquires Blackford Analysis, Strengthening AI Orchestration Capabilities Across Its HealthTech Portfolioprnewswire.com